Literature DB >> 1924394

Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells.

K Alheim1, C Andersson, S Tingsborg, M Ziolkowska, M Schultzberg, T Bartfai.   

Abstract

Expression of the cytokine interleukin 1 alpha (IL-1 alpha) was demonstrated in the rat PC12 pheochromocytoma cell line by (i) immunohistochemistry using rabbit polyclonal antisera raised against the recombinant murine IL-1 alpha, (ii) an ELISA, and (iii) a specific cell conversion bioassay based on the use of LBRM33-1A5 cells. IL-1 alpha mRNA was demonstrated in the PC12 cells, by PCR amplification. Constitutive expression of IL-1 alpha in PC12 cells was demonstrated in all experiments, although the cellular levels of IL-1 alpha-like immunoreactivity varied. The expression of IL-1 alpha, as studied at the mRNA level, was inducible by mouse nerve growth factor (7S NGF), and the gene product level was inducible in a dose- and time-dependent fashion by 7S NGF. The maximum induction corresponds to a 600% increase in IL-1 alpha-like immunoreactivity above the expression level found in noninduced cells and occurred after a 3-day incubation of the cells with NGF at 0.75 micrograms/ml of culture medium. The significance of the ability of NGF to induce IL-1 expression lies in the fact that IL-1 itself also acts as a growth factor that promotes glial proliferation and, even more importantly, IL-1 itself induces the expression of NGF at peripheral nerve injury [Lindholm, D., Heumann, R., Meyer, M. & Thoenen, H. (1987) Nature (London) 330, 658-659].

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924394      PMCID: PMC52702          DOI: 10.1073/pnas.88.20.9302

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Selective induction of brain type II Na+ channels by nerve growth factor.

Authors:  G Mandel; S S Cooperman; R A Maue; R H Goodman; P Brehm
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates.

Authors:  S Alonso; A Minty; Y Bourlet; M Buckingham
Journal:  J Mol Evol       Date:  1986       Impact factor: 2.395

3.  Interleukin-1-like immunoreactivity in peripheral tissues.

Authors:  M Schultzberg; S B Svenson; A Unden; T Bartfai
Journal:  J Neurosci Res       Date:  1987       Impact factor: 4.164

Review 4.  Adrenal medullary chromaffin cells in vitro.

Authors:  B G Livett
Journal:  Physiol Rev       Date:  1984-10       Impact factor: 37.312

5.  Molecular probes for the development and plasticity of neural crest derivatives.

Authors:  D J Anderson; R Axel
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

6.  Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve.

Authors:  D Lindholm; R Heumann; M Meyer; H Thoenen
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

7.  Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep.

Authors:  S Shoham; D Davenne; A B Cady; C A Dinarello; J M Krueger
Journal:  Am J Physiol       Date:  1987-07

8.  Interleukin-1 is an astroglial growth factor in the developing brain.

Authors:  D Giulian; D G Young; J Woodward; D C Brown; L B Lachman
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

9.  Regulation of protein kinase activities in PC12 pheochromocytoma cells.

Authors:  J Blenis; R L Erikson
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

10.  Nerve growth factor action is mediated by cyclic AMP- and Ca+2/phospholipid-dependent protein kinases.

Authors:  J Cremins; J A Wagner; S Halegoua
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

View more
  9 in total

1.  Intrahepatic cholestasis as a paraneoplastic syndrome associated with pheochromocytoma.

Authors:  C H Chung; C H Wang; C Y Tzen; C P Liu
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

2.  Human placenta and fetal membranes express nerve growth factor mRNA and protein.

Authors:  P Toti; P Ciarmela; P Florio; N Volpi; R Occhini; F Petraglia
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

3.  Expression of interleukin-1 in human pheochromocytoma.

Authors:  S R Bornstein; M Ehrhart-Bornstein; J González-Hernández; S Schröder; W A Scherbaum
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

4.  TLR2 is required for the altered transcription of p75NGF receptors in gram positive infection.

Authors:  Sebastian A Wirz; Peter S Tobias; Richard J Ulevitch; Laurence Aribibe; Tamas Bartfai
Journal:  Neurochem Res       Date:  2006-03-03       Impact factor: 3.996

5.  IL-1 is expressed in human adrenal gland in vivo. Possible role in a local immune-adrenal axis.

Authors:  J A González-Hernández; S R Bornstein; M Ehrhart-Bornstein; J E Gschwend; A Gwosdow; G Jirikowski; W A Scherbaum
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

6.  Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation.

Authors:  L Aloe; M A Tuveri; R Levi-Montalcini
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

7.  Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome.

Authors:  M Minetto; A Dovio; M Ventura; S Cappia; F Daffara; M Terzolo; A Angeli
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

8.  Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia.

Authors:  Tomoya Terashima; Nobuhiro Ogawa; Yuki Nakae; Toshiyuki Sato; Miwako Katagi; Junko Okano; Hiroshi Maegawa; Hideto Kojima
Journal:  Mol Ther Nucleic Acids       Date:  2018-02-27       Impact factor: 8.886

Review 9.  Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.

Authors:  Collin J Byrne; Sandhya Khurana; Aseem Kumar; T C Tai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-28       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.